Introduction – A New Chapter in Drug DevelopmentChapter 1 – The Biomarker Revolution in Early Ph...
03
Jun
By Dr Hayley Kain, Pharmacokinetic Scientist at Agilex Biolabs Rapid Data. Smarter Decisions. No...
By Dr. Kurt Sales, CSO Section Summary: How Agilex has emerged as a leader to support the ris...
By Dr. Kurt Sales, CSO Summary The following article focuses on the use of flow cytometry in c...
By William Grenfell, Head of IT In today's digital age, information security is paramount. At Agi...
By Kim Salvatore, Head of Client and Operational Services The bioanalytical and drug development...
There’s a great opportunity for Australian SME’s to take advantage of a well-deserved subsidy!...
Research shows that Biotechnology companies have been facing significant challenges – with continu...
By Dr. Kurt Sales, CSO Introduction Immunological assays are essential in drug development, es...
By Dr. Kurt Sales, CSO Peripheral Blood Mononuclear Cells (PBMC) are critical for the pharmacodyn...
